We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.
- Authors
Quinn, Joseph F; Raman, Rema; Thomas, Ronald G; Yurko-Mauro, Karin; Nelson, Edward B; Van Dyck, Christopher; Galvin, James E; Emond, Jennifer; Jack, Clifford R, Jr; Weiner, Michael; Shinto, Lynne; Aisen, Paul S
- Abstract
Docosahexaenoic acid (DHA) is the most abundant long-chain polyunsaturated fatty acid in the brain. Epidemiological studies suggest that consumption of DHA is associated with a reduced incidence of Alzheimer disease. Animal studies demonstrate that oral intake of DHA reduces Alzheimer-like brain pathology.
- Publication
JAMA, 2010, Vol 304, Issue 17, p1903
- ISSN
1538-3598
- Publication type
Journal Article
- DOI
10.1001/jama.2010.1510